Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Leukoencephalopathy with vanishing white matter is a recently defined autosomal recessive disorder. The course is chronic progressive with additional episodes of rapid deterioration, provoked by fever and minor head trauma. A previous study showed that mutations in the genes encoding the ε‐ or the β‐subunit of the eukaryotic translation initiation factor eIF2B, a complex consisting of five subunits, cause the disease in most patients. Seven unsolved patients remained. The unsolved patients were investigated by mutation analysis of the genes encoding the α‐, γ‐, and δ‐subunit of eIF2B and the gene encoding the α‐subunit of eIF2, because phosphorylation of this latter subunit regulates eIF2B activity. Mutations were found in the genes encoding the α‐ (1 patient), γ‐ (2 patients), and δ‐subunits (2 patients) of eIF2B, but no mutations were found in the gene encoding the α‐subunit of eIF2. In 2, both less typical patients, no mutations were found. Mutations in all five genes eIF2B subunit genes can cause VWM. eIF2B is essential for the initiation of translation of RNA into protein and is involved in regulation of the process, especially under circumstances of stress, such as fever. A defect in eIF2B may explain the sensitivity to stress factors in vanishing white matter patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Welch, W. J. (1992) · Physiological Reviews · doi:10.1152/physrev.1992.72.4.1063 · Cited by 1,190
Translational control of gene expression
Hannig, E. M. (2001) · BioEssays · doi:10.1002/bies.1108 · Cited by 1,189
Initiation of Protein Synthesis in Eukaryotic Cells
Pain, V. M. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00747.x · Cited by 707
(1991) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240470805 · Cited by 431
Leegwater, P. A. J., Vermeulen, G., Könst, A. A. M., Naidu, S., Mulders, J., Visser, A., Kersbergen, P., Mobach, D., Fonds, D., van Berkel, C. G. M., et al. (2001) · Nature Genetics · doi:10.1038/ng764 · Cited by 414
Self-citationA new leukoencephalopathy with vanishing white matter
van der Knaap, M. S., Barth, P. G., Gabreëls, F. J. M., Franzoni, E., Begeer, J. H., Stroink, H., Rotteveel, J. J., & Valk, J. (1997) · Neurology · doi:10.1212/wnl.48.4.845 · Cited by 392
Self-citationAsano, K., Clayton, J., Shalev, A., & Hinnebusch, A. G. (2000) · Genes & Development · doi:10.1101/gad.831800 · Cited by 302
Childhood ataxia with diffuse central nervous system hypomyelination
Schiffmann, R., Moller, J. R., Trapp, B. D., Shih, H. H., Farrer, R. G., Katz, D. A., Alger, J. R., Parker, C. C., Hauer, P. E., Kaneski, C. R., et al. (1994) · Annals of Neurology · doi:10.1002/ana.410350314 · Cited by 261
Defining and Categorizing Leukoencephalopathies of Unknown Origin: MR Imaging Approach
van der Knaap, M. S., Breiter, S. N., Naidu, S., Hart, A. A. M., & Valk, J. (1999) · Radiology · doi:10.1148/radiology.213.1.r99se01121 · Cited by 241
Self-citationPhenotypic variation in leukoencephalopathy with vanishing white matter
van der Knaap, M. S., Kamphorst, W., Barth, P. G., Kraaijeveld, C. L., Gut, E., & Valk, J. (1998) · Neurology · doi:10.1212/wnl.51.2.540 · Cited by 196
Self-citation
Cited by
The integrated stress response: From mechanism to disease
Costa-Mattioli, M., & Walter, P. (2020) · Science · doi:10.1126/science.aat5314 · Cited by 1,617
“VWM is characterized by myelin loss and progressive neurological symptoms, such as ataxia, spasticity, cognitive deterioration and, ultimately, death (90).”
BackgroundInfluentialTRANSLATIONAL REGULATION OF GCN4 AND THE GENERAL AMINO ACID CONTROL OF YEAST
Hinnebusch, A. G. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.59.031805.133833 · Cited by 1,251
Myelination and support of axonal integrity by glia
Nave, K.-A. (2010) · Nature · doi:10.1038/nature09614 · Cited by 1,062
Pushing the limits of the scanning mechanism for initiation of translation
Kozak, M. (2002) · Gene · doi:10.1016/s0378-1119(02)01056-9 · Cited by 919
Regulation of translation via mRNA structure in prokaryotes and eukaryotes
Kozak, M. (2005) · Gene · doi:10.1016/j.gene.2005.06.037 · Cited by 747
Myelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes-Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 728
Goswami, D., & Conway, G. S. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi012 · Cited by 713
Prioritizing candidate disease genes by network-based boosting of genome-wide association data
Lee, I., Blom, U. M., Wang, P. I., Shim, J. E., & Marcotte, E. M. (2011) · Genome Research · doi:10.1101/gr.118992.110 · Cited by 686
Role of eIF2α Kinases in Translational Control and Adaptation to Cellular Stress
Wek, R. C. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a032870 · Cited by 543
Cerebral White Matter: Neuroanatomy, Clinical Neurology, and Neurobehavioral Correlates
Schmahmann, J. D., Smith, E. E., Eichler, F. S., & Filley, C. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1444.017 · Cited by 486
van der Knaap, M. S., & Bugiani, M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1739-1 · Cited by 403
“VWM is caused by recessive mutations in any of the five genes (EIF2B1, EIF2B2, EIF2B3, EIF2B4, and EIF2B5) encoding the subunits of eukaryotic translation initiation factor 2B (eIF2B, subunits α, β, γ, δ and ε) [240].”
BackgroundVanishing white matter disease
van der Knaap, M. S., Pronk, J. C., & Scheper, G. C. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70440-9 · Cited by 324
Self-citationOgilvie, I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26020 · Cited by 279
Endoplasmic reticulum stress and eIF2α phosphorylation: The Achilles heel of pancreatic β cells
Cnop, M., Toivonen, S., Igoillo-Esteve, M., & Salpea, P. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.06.001 · Cited by 268
Translation matters: protein synthesis defects in inherited disease
Scheper, G. C., van der Knaap, M. S., & Proud, C. G. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2142 · Cited by 264
Self-citationtRNA splicing endonuclease mutations cause pontocerebellar hypoplasia
Budde, B. S., Namavar, Y., Barth, P. G., Poll-The, B. T., Nürnberg, G., Becker, C., van Ruissen, F., Weterman, M. A. J., Fluiter, K., T te Beek, E., et al. (2008) · Nature Genetics · doi:10.1038/ng.204 · Cited by 251
“Notably, many neurological disorders are caused by mutations in genes involved in essential cellular processes: for example, mutations in the genes encoding subunits of the translation initiation factor EIF2B give rise to vanishing white matter disease, and defects in the mitochondrial translation machinery can lead t…”
BackgroundSelf-citationStratification of astrocytes in healthy and diseased brain
Verkhratsky, A., Zorec, R., & Parpura, V. (2017) · Brain Pathology · doi:10.1111/bpa.12537 · Cited by 236
eIF2B activator prevents neurological defects caused by a chronic integrated stress response
Wong, Y. L., LeBon, L., Basso, A. M., Kohlhaas, K. L., Nikkel, A. L., Robb, H. M., Donnelly-Roberts, D. L., Prakash, J., Swensen, A. M., Rubinstein, N. D., et al. (2019) · eLife · doi:10.7554/elife.42940 · Cited by 236
Ovarian Failure Related to Eukaryotic Initiation Factor 2B Mutations
Fogli, A., Rodriguez, D., Eymard-Pierre, E., Bouhour, F., Labauge, P., Meaney, B. F., Zeesman, S., Kaneski, C. R., Schiffmann, R., & Boespflug-Tanguy, O. (2003) · The American Journal of Human Genetics · doi:10.1086/375404 · Cited by 199
“For EIF2B2 and EIF2B4, the combinations of heterozygous mutations found in our patients with ovarioleukodystrophy were different from those described in a pool of patients with CACH/VWM (van der Knaap et al. 2002).”
BackgroundMethodResultInfluentialMitochondria: Impaired mitochondrial translation in human disease
Boczonadi, V., & Horvath, R. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.12.011 · Cited by 193
Leukoencephalopathy with vanishing white matter: a review
Bugiani, M., Boor, I., Powers, J. M., Scheper, G. C., & van der Knaap, M. S. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181f2eafa · Cited by 189
From syndrome families to functional genomics
Brunner, H. G., & van Driel, M. A. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1383 · Cited by 175
Baba, Y., Ghetti, B., Baker, M. C., Uitti, R. J., Hutton, M. L., Yamaguchi, K., Bird, T., Lin, W., DeLucia, M. W., Dickson, D. W., et al. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0046-z · Cited by 106
Mallucci, G. R., Klenerman, D., & Rubinsztein, D. C. (2020) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-040320-120625 · Cited by 62
Taymans, J.-M., Nkiliza, A., & Chartier-Harlin, M.-C. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.05.004 · Cited by 50
De Franco, E., Caswell, R., Johnson, M. B., Wakeling, M. N., Zung, A., Dũng, V. C., Bích Ngọc, C. T., Goonetilleke, R., Vivanco Jury, M., El-Khateeb, M., et al. (2020) · Diabetes · doi:10.2337/db19-1029 · Cited by 39
“Our patients’ clinical features are markedly different from those reported in patients with leukoencephalopathy with vanishing white matter (VWM), a rare pediatric neurological disease caused by recessive loss-of-function EIF2B1 mutations (13).”
ResultAxonal abnormalities in vanishing white matter.
Klok, M. D., Bugiani, M., de Vries, S. I., Gerritsen, W., Breur, M., van der Sluis, S., Heine, V. M., Kole, M. H. P., Baron, W., & van der Knaap, M. S. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.540 · Cited by 38
“VWM is caused by mutations in the genes encoding the five subunits of the eukaryotic translation initiation factor 2B (eIF2B), EIF2B1 through EIF2B5.”
Background(2010) · PubMed Central · Cited by 27
Metadata
- Authors
- van der Knaap, M. S., Leegwater, P. A. J., Könst, A. A. M., Visser, A., Naidu, S., Oudejans, C. B. M., Schutgens, R. B. H., & Pronk, J. C.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2001-12-27
- Volume
- 51
- Issue
- 2
- Pages
- 264-270
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2065556020
- Cited by
- 381
- References
- 23
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.